120 filings
Page 2 of 6
8-K
cwgq06o81er
14 Apr 11
Human Genome Sciences Updates Investors on Progress of Benlysta® Launch and Future Priorities
12:00am
8-K
t7cl8ilwn iekx
14 Mar 11
Departure of Directors or Certain Officers
12:00am
8-K
7daq93z
10 Mar 11
Human Genome Sciences and Glaxosmithkline Announcefda Approval of Benlysta® (Belimumab) for Treatment of Systemic Lupus Erythematosus
12:00am
8-K
v11wr9tal0ks
24 Feb 11
Human Genome Sciences Announces Fourth-quarter and Full-year Financial Results and Key Developments
12:00am
8-K
06gjkwc 2yze63
21 Jan 11
Departure of Directors or Certain Officers
12:00am
8-K
4zw 4lu6a
10 Jan 11
Human Genome Sciences Reports Progress Toward Sustainable Revenues and Announces 2011 Goals at Jpmorgan Healthcare Conference
12:00am
8-K
4jyi665fq1
14 Dec 10
Departure of Directors or Certain Officers
12:00am
8-K
kjn14k2bni8k95r af
8 Nov 10
Regulation FD Disclosure
12:00am
8-K
hh1l2h uplowm
27 Oct 10
Human Genome Sciences Announces Third Quarter 2010 Financial Results and Key Developments
12:00am
8-K
7hdjivi 3z
6 Oct 10
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
j2oq7n 0oz
13 Sep 10
Regulation FD Disclosure
12:00am
8-K
4e7hbj0b
22 Jul 10
Human Genome Sciences Announces Second Quarter 2010 Financial Results and Key Developments
12:00am
8-K
5a4r7jolio
24 May 10
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
hasrc7t
29 Apr 10
Human Genome Sciences Announces First Quarter 2010 Financial Results and Key Developments
12:00am
8-K
ip6xq6rgati0e2 5dvl
10 Mar 10
Human Genome Sciences Appoints David P. Southwell Executive Vice President and Chief Financial Officer
12:00am
8-K
6h2c9w9mvb nms3
3 Mar 10
Departure of Directors or Certain Officers
12:00am
8-K
xbrk zwfy894
2 Mar 10
Human Genome Sciences Announces Fourth-quarter and Full-year 2009 Financial Results and Key Developments
12:00am
8-K
t9t1yaq
1 Mar 10
Departure of Directors or Certain Officers
12:00am
8-K
beh0t
11 Jan 10
Results of Operations and Financial Condition
12:00am
8-K
k0vt8 7mf6msvv9idgx
8 Dec 09
Human Genome Sciences Announces Pricing of Public Offering of Common Stock
12:00am